Keyphrases
Head-and-neck Cancer
100%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
90%
Head-and-neck
62%
Tumor
38%
Squamous Cell Carcinoma of Head
31%
Tumor Cells
25%
Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
22%
Chronic Rhinosinusitis
19%
Squamous Cell Cancer
16%
Hearing Impairment
16%
Nasal Polyps
15%
Active Middle Ear Implant
12%
Toll-like
12%
Radiotherapy
11%
Hearing Aids
11%
Overall Survival
10%
Germany
10%
Cisplatin
10%
Squamous Carcinoma Cells
10%
Plasmacytoid Dendritic Cells
10%
Abbreviated Profile of Hearing Aid Benefit
10%
Stem Cells
9%
Natural Killer Cells
9%
Locally Advanced
9%
Vibrant Soundbridge
8%
Advanced Squamous Cell Carcinoma
8%
Paclitaxel
8%
Cancer Patients
8%
Neck Surgery
8%
Head-and-neck Region
8%
Carcinoma Cell Lines
8%
Bispecific Antibody
8%
Clinical Trials
7%
Epithelial Cell Adhesion Molecule (EpCAM)
7%
Metastasis
7%
Upper Airway Stimulation
7%
Radiochemotherapy
7%
Hearing Aid Fitting
7%
Treatment Options
7%
Chat Generative Pre-trained Transformer (ChatGPT)
7%
Carcinoma
7%
Gene Therapy
7%
German Society
7%
Myeloid Dendritic Cells
7%
1,8-cineole
7%
Salivary Gland
7%
Mepolizumab
7%
Platelets
6%
Tumor Stage
6%
Brachytherapy
6%
Medicine and Dentistry
Head and Neck Cancer
69%
Neoplasm
64%
Neck
44%
Head and Neck Squamous Cell Carcinoma
41%
Squamous Cell Carcinoma
25%
Diseases
20%
Chronic Rhinosinusitis
20%
Nasal Polyp
20%
Tumor Cell
17%
Stem Cell
15%
Radiation Therapy
15%
Malignant Neoplasm
14%
Overall Survival
12%
Middle Ear Implantation
11%
Cancer Cell
11%
Squamous Cell
11%
Metastatic Carcinoma
10%
Chemoradiotherapy
10%
Head and Neck Surgery
10%
Immunotherapy
9%
Biological Marker
9%
Salivary Gland
9%
Clinical Trial
9%
Cancer
9%
Recurrent Disease
9%
Laryngeal Cancer
8%
Otorhinolaryngology
8%
Hearing Impairment
8%
Atresia
7%
Brachytherapy
7%
Larynx
7%
In Vitro
7%
Mepolizumab
7%
Laryngectomy
6%
Obstructive Sleep Apnea
6%
Head and Neck Tumor
6%
Parotid Gland
6%
Lymph Node Metastasis
6%
Cisplatin
6%
Quality of Life
6%
Paclitaxel
5%
Infection
5%
Otoplasty
5%
Clostridium Botulinum Type A
5%
Head and Neck Squamous Cell Carcinoma Cell Line
5%
Primary Tumor
5%
Neck Dissection
5%
Cancer Therapy
5%
Bone Conduction
5%
Survival Rate
5%